Sivabal Sivaloganathan
Overview
Explore the profile of Sivabal Sivaloganathan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghasemi M, Chang S, Sivaloganathan S
Bull Math Biol
. 2024 Aug;
86(9):117.
PMID: 39112686
In this study we employ computational methods to investigate the influence of aeration strategies on simultaneous nitrification-denitrification processes. Specifically, we explore the impact of periodic and intermittent aeration on denitrification...
2.
Ghasemi M, Yu A, Sivaloganathan S
Ultrason Sonochem
. 2022 Feb;
83:105948.
PMID: 35151989
Acoustic droplet vaporization (ADV) is a new approach to generate vapor bubbles that have potentially broad medical applications. ADV-generated bubbles can be used as contrast agents in acoustic imaging, as...
3.
Forouzannia F, Sivaloganathan S, Kohandel M
Math Biosci Eng
. 2020 Oct;
17(5):5250-5266.
PMID: 33120551
The tumour control probability (TCP) is a treatment planning tool that evaluates the probability of tumour eradication and helps in the assessment of the relative efficacy of different radiotherapy regimens....
4.
Ghasemi M, Sivaloganathan S
Math Biosci
. 2020 Aug;
329:108456.
PMID: 32841615
The application of local hyperthermia, particularly in conjunction with other treatment strategies (like chemotherapy and radiotherapy) has been known to be a useful means of enhancing tumor treatment outcomes. However,...
5.
Ghasemi M, Jenkins B, Doxey A, Sivaloganathan S
J Theor Biol
. 2019 Oct;
485:110053.
PMID: 31628906
One of a number of critical roles played by NO· as a chemical weapon (generated by the immune system) is to neutralize pathogens. However, the virulence of pathogens depends on...
6.
Taheri-Araghi S, Chen D, Kohandel M, Sivaloganathan S, Foldvari M
Nanoscale
. 2018 Dec;
11(3):1037-1046.
PMID: 30569915
Gemini nanoparticles (NPs) are a family of non-viral gene delivery systems with potential for applications in non-invasive gene therapy. Translation of these non-viral gene delivery systems requires improvement of transfection...
7.
Mahdipour-Shirayeh A, Kaveh K, Kohandel M, Sivaloganathan S
PLoS One
. 2017 Oct;
12(10):e0187000.
PMID: 29084232
The unwelcome evolution of malignancy during cancer progression emerges through a selection process in a complex heterogeneous population structure. In the present work, we investigate evolutionary dynamics in a phenotypically...
8.
Molavian H, Kohandel M, Sivaloganathan S
Front Physiol
. 2016 Sep;
7:362.
PMID: 27601999
Since the original observation of the Warburg Effect in cancer cells, over 8 decades ago, the major question of why aerobic glycolysis is favored over oxidative phosphorylation has remained unresolved....
9.
Molavian H, Goldman A, Phipps C, Kohandel M, Wouters B, Sengupta S, et al.
Sci Rep
. 2016 Jun;
6:27439.
PMID: 27278439
Pharmacological concentrations of small molecule natural products, such as ascorbic acid, have exhibited distinct cell killing outcomes between cancer and normal cells whereby cancer cells undergo apoptosis or necrosis while...
10.
Goriely A, Geers M, Holzapfel G, Jayamohan J, Jerusalem A, Sivaloganathan S, et al.
Biomech Model Mechanobiol
. 2015 Feb;
14(5):931-65.
PMID: 25716305
The human brain is the continuous subject of extensive investigation aimed at understanding its behavior and function. Despite a clear evidence that mechanical factors play an important role in regulating...